Sudeep Pharma Limited (SUDEEPPHRM) — Board Meeting

📢 Key Event
Board approved audited FY26 financials and proposed ₹1.50 final dividend per share.

🔄 What Changed
Recommended ₹1.50 final dividend (150% payout) pending AGM approval; appointed new auditors pending shareholder ratification.

🔮 What's Next
None

💡 Investor Takeaway
The proposed dividend signals confidence in FY26 profitability, but requires shareholder approval at the upcoming AGM before payout.

Sudeep Pharma Limited announced the outcome of its 21 May 2026 board meeting, approving audited standalone and consolidated financial results for the quarter and year ended 31 March 2026. The board recommended a final dividend of ₹1.50 per share (150% payout) subject to shareholder approval at the upcoming AGM. It also appointed Chetan Gandhi & Associates as cost auditors for FY 2026-27 and H M Mehta & Associates as secretarial auditors for five consecutive years (2026-27 to 2030-31), pending shareholder ratification. The filing includes auditor's reports confirming an unmodified opinion and compliance with SEBI LODR and Ind AS 34 standards.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUDEEPPHRM ✨ Ask AI About This